Abstract
The complex neurodevelopmental disorder schizophrenia is thought to be induced by an interaction between predisposing genes and environmental stressors. In order to get a better insight into the aetiology of this complex disorder, animal models have been developed. In this review, we summarize mRNA expression profiling studies on neurodevelopmental, pharmacological and genetic animal models for schizophrenia. We discuss parallels and contradictions among these studies, and propose strategies for future research.
Keywords: Animal model, behavior, genetics, microarray, mRNA expression, neurodevelopment, pharmacology, Gene Expression, Rodent Models, Schizophrenia, delusions, hallucinations, ganized speech, grossly disorganized, catatonic behaviour, negative symptoms, neuregulin-1, transferase, hyperlocomotion, social withdrawal, loss of prepulse, cognitive deficits, serotonin, Affymetrix, quantitative polymerase chain reaction, astrocytes, hippocampus, cytokine, apoptosis, calcium/calmodulin signaling, neurotransmitter, VH lesions, haloperidol, mitochondrial cytochrome, oxidase, chondrial tRNA, isoforms, adenosine, transthyretin, glutamate, substances, phencyclidine, prefrontal cortex, Leiomodin 2, ketamine, cyclo-oxygenase, NMDA receptor, MK-801
Current Neuropharmacology
Title: Gene Expression Profiling in Rodent Models for Schizophrenia
Volume: 8 Issue: 4
Author(s): Jessica E. Van Schijndel and Gerard J.M. Martens
Affiliation:
Keywords: Animal model, behavior, genetics, microarray, mRNA expression, neurodevelopment, pharmacology, Gene Expression, Rodent Models, Schizophrenia, delusions, hallucinations, ganized speech, grossly disorganized, catatonic behaviour, negative symptoms, neuregulin-1, transferase, hyperlocomotion, social withdrawal, loss of prepulse, cognitive deficits, serotonin, Affymetrix, quantitative polymerase chain reaction, astrocytes, hippocampus, cytokine, apoptosis, calcium/calmodulin signaling, neurotransmitter, VH lesions, haloperidol, mitochondrial cytochrome, oxidase, chondrial tRNA, isoforms, adenosine, transthyretin, glutamate, substances, phencyclidine, prefrontal cortex, Leiomodin 2, ketamine, cyclo-oxygenase, NMDA receptor, MK-801
Abstract: The complex neurodevelopmental disorder schizophrenia is thought to be induced by an interaction between predisposing genes and environmental stressors. In order to get a better insight into the aetiology of this complex disorder, animal models have been developed. In this review, we summarize mRNA expression profiling studies on neurodevelopmental, pharmacological and genetic animal models for schizophrenia. We discuss parallels and contradictions among these studies, and propose strategies for future research.
Export Options
About this article
Cite this article as:
E. Van Schijndel Jessica and J.M. Martens Gerard, Gene Expression Profiling in Rodent Models for Schizophrenia, Current Neuropharmacology 2010; 8 (4) . https://dx.doi.org/10.2174/157015910793358132
DOI https://dx.doi.org/10.2174/157015910793358132 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Meet Our Editorial Board Member
Pharmaceutical Nanotechnology Nutrition in Infancy
Current Pediatric Reviews Cells Under Pressure – Treatment of Eukaryotic Cells with High Hydrostatic Pressure, from Physiologic Aspects to Pressure Induced Cell Death
Current Medicinal Chemistry Immunotherapy Resistance Mechanisms in Renal Cell Cancer
Current Signal Transduction Therapy Molecular Biomarkers for Lung Adenocarcinoma: A Short Review
Current Cancer Therapy Reviews Association of p53 with Bid Induces Cell Death in Response to Etoposide Treatment in Hepatocellular Carcinoma
Current Cancer Drug Targets Targeting the Endocannabinoid System for the Treatment of Cancer – A Practical View
Current Topics in Medicinal Chemistry Therapeutic Perspectives for cN-II in Cancer.
Current Medicinal Chemistry Role of the Hypoxic Microenvironment in the Antitumor Activity of Tyrosine Kinase Inhibitors
Current Medicinal Chemistry Drug-Induced Thromboembolic Events in Patients with Malignancy
Cardiovascular & Hematological Disorders-Drug Targets Effects of Bioactive Compounds from Carrots (Daucus carota L.), Polyacetylenes, Beta-Carotene and Lutein on Human Lymphoid Leukaemia Cells
Anti-Cancer Agents in Medicinal Chemistry In Vitro Models of Human T Cell Development: Dishing Out Progenitor T Cells
Current Immunology Reviews (Discontinued) Do Not Say Ever Never More: The Ins and Outs of Antiangiogenic Therapies
Current Pharmaceutical Design Exposure and Genotoxicity Assessment Methodologies - The Case of Formaldehyde Occupational Exposure
Current Analytical Chemistry Drugs, Environmental Factors, Loci and Genes Involved in Nonsyndromic Orofacial Cleft
Current Pharmacogenomics The Phosphoinositide 3-Kinase (PI3K)/AKT Signaling Pathway as a Therapeutic Target for the Treatment of Human Acute Myeloid Leukemia (AML)
Current Signal Transduction Therapy Pharmacological Activation of p53 in Cancer Cells
Current Pharmaceutical Design MicroRNA Expression in Coronary Artery Disease
MicroRNA Optimization of Lentiviral Vectors Generation for Biomedical and Clinical Research Purposes: Contemporary Trends in Technology Development and Applications
Current Gene Therapy Glucocorticoid Receptors and Bone
Current Pharmaceutical Design